These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3917561)

  • 41. Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients.
    Yamamoto Y; Takahashi Y; Suzuki E; Mishima N; Inoue K; Itoh K; Kagawa Y; Inoue Y
    Epilepsy Res; 2012 Sep; 101(3):202-9. PubMed ID: 22542569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
    Mattei A; Bernard G; Plauchu G; Paliard P
    Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
    [No Abstract]   [Full Text] [Related]  

  • 44. Diagnosis of argininosuccinic aciduria after valproic acid-induced hyperammonemia.
    Morgan HB; Swaiman KF; Johnson BD
    Neurology; 1987 May; 37(5):886-7. PubMed ID: 3106853
    [No Abstract]   [Full Text] [Related]  

  • 45. Valproate-associated hyperammonemia and DL-carnitine supplement.
    Komatsu M; Kodama S; Yokoyama S; Konishi H; Tanaka K; Momota K; Wada H; Matsuo T
    Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
    [No Abstract]   [Full Text] [Related]  

  • 46. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Alterations of the state of consciousness induced by valproic acid: 6 case reports].
    Campostrini R; Paganini M; Boncinelli L; Zaccara G; Arnetoli G; Zappoli R
    Riv Patol Nerv Ment; 1983; 104(1):23-34. PubMed ID: 6431599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The real mechanism of VPA-induced hyperammonemia remains unknown.
    Hung CC; Li TM; Wei IH; Huang CC
    Gen Hosp Psychiatry; 2011; 33(1):84.e3-4. PubMed ID: 21353142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
    Ettlin T; Scollo-Lavizzari G
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
    [No Abstract]   [Full Text] [Related]  

  • 50. Adult nonhepatic hyperammonemia: a case report and differential diagnosis.
    LaBuzetta JN; Yao JZ; Bourque DL; Zivin J
    Am J Med; 2010 Oct; 123(10):885-91. PubMed ID: 20920686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for hyperammonemia in pediatric patients with epilepsy.
    Yamamoto Y; Takahashi Y; Imai K; Mishima N; Yazawa R; Inoue K; Itoh K; Kagawa Y; Inoue Y
    Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inherited and acquired syndromes of hyperammonemia and encephalopathy in children.
    Treem WR
    Semin Liver Dis; 1994 Aug; 14(3):236-58. PubMed ID: 7939785
    [No Abstract]   [Full Text] [Related]  

  • 53. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.
    Honeycutt D; Callahan K; Rutledge L; Evans B
    Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valproate-induced encephalopathy.
    Chen WT; Yen DJ; Yu HY; Liao KK
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):474-8. PubMed ID: 11720147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?
    Nicolai J; Carr RB
    Epilepsy Behav; 2008 Apr; 12(3):494-6; discussion 497-8. PubMed ID: 18162442
    [No Abstract]   [Full Text] [Related]  

  • 58. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 59. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valproic acid-associated encephalopathy with coma.
    Settle EC
    Am J Psychiatry; 1995 Aug; 152(8):1236-7. PubMed ID: 7625483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.